Interestingly, lower-risk MDS (LR-MDS) patients (IPSS-R ≤ 3.5) with an abnormal low level of CD34 + CD38+HSPCs entropy had an adverse outcome. The gene discussed is CD34; the disease is myelodysplastic syndrome.